Range Financial Group LLC Acquires New Stake in Bausch Health Companies Inc. (NYSE:BHC)

Range Financial Group LLC acquired a new position in Bausch Health Companies Inc. (NYSE:BHC) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 124,534 shares of the company’s stock, valued at approximately $1,004,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Certuity LLC purchased a new position in shares of Bausch Health Companies in the 2nd quarter worth about $75,000. Private Management Group Inc. grew its holdings in shares of Bausch Health Companies by 43.0% during the 2nd quarter. Private Management Group Inc. now owns 1,495,953 shares of the company’s stock valued at $10,427,000 after purchasing an additional 449,623 shares during the last quarter. Headlands Technologies LLC purchased a new position in Bausch Health Companies in the 2nd quarter worth $35,000. Brown Brothers Harriman & Co. bought a new stake in Bausch Health Companies in the second quarter worth $109,000. Finally, Dimensional Fund Advisors LP boosted its position in Bausch Health Companies by 12.1% during the second quarter. Dimensional Fund Advisors LP now owns 3,165,512 shares of the company’s stock valued at $22,063,000 after buying an additional 341,936 shares during the period. 78.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

BHC has been the subject of a number of recent research reports. StockNews.com raised Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Friday, October 25th. Royal Bank of Canada boosted their price objective on Bausch Health Companies from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Friday, November 1st. Finally, Evercore ISI upgraded shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $7.75.

Bausch Health Companies Stock Up 0.5 %

Shares of BHC traded up $0.04 during mid-day trading on Tuesday, hitting $7.84. 816,999 shares of the company’s stock traded hands, compared to its average volume of 939,080. The firm has a market capitalization of $2.84 billion, a P/E ratio of -16.33 and a beta of 0.69. The business’s 50-day moving average price is $8.23 and its 200-day moving average price is $7.40. Bausch Health Companies Inc. has a 1 year low of $3.96 and a 1 year high of $11.46.

Bausch Health Companies (NYSE:BHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.02 by $0.10. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.42 billion. Bausch Health Companies had a negative net margin of 1.88% and a negative return on equity of 755.86%. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.03 EPS. Sell-side analysts anticipate that Bausch Health Companies Inc. will post 3.74 earnings per share for the current fiscal year.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.